Health Care [ 9/12 ] | Biotechnology [ 43/74 ]
NASDAQ | Common Stock
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits.
It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services.
In addition, the company offers listing sponsorship and consultancy services.
OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 31, 25 | 0.34 Increased by +128.91% | - |
| Aug 18, 25 | 0.42 Increased by +116.67% | -0.06 Increased by +800.00% |
| May 30, 25 | -0.04 Increased by +99.70% | - |
| Nov 12, 24 | 1.35 Increased by +394.00% | -0.06 Increased by +2.35 K% |
| Jul 8, 24 | -1.18 Decreased by -26.46% | - |
| Jun 24, 24 | -2.52 Decreased by -101.60% | -0.13 Decreased by -1.84 K% |
| Mar 26, 24 | -13.29 Decreased by -243.30% | - |
| Nov 14, 23 | -0.46 Increased by +92.33% | -0.43 Decreased by -6.98% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 4.00 M Increased by +14.19 K% | -608.73 K Increased by +61.38% | Decreased by -15.22% Increased by +99.73% |
| Jun 30, 25 | 5.00 M Increased by +367.29% | 4.35 M Increased by +125.53% | Increased by +87.00% Increased by +105.46% |
| Dec 31, 24 | 5.00 M Increased by +367.41% | 4.35 M Increased by +125.53% | Increased by +87.00% Increased by +105.46% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | 8.93 M Increased by +319.81% | Increased by +N/A% Increased by +N/A% |
| Jun 30, 24 | 28.00 K Decreased by -96.20% | -1.58 M Increased by +72.95% | Decreased by -5.63 K% Decreased by -611.07% |
| Mar 31, 24 | 1.07 M Increased by +17.14% | -17.04 M Decreased by -197.05% | Decreased by -1.59 K% Decreased by -153.59% |
| Dec 31, 23 | 1.07 M Increased by +48.24% | -17.04 M Decreased by -61.76% | Decreased by -1.59 K% Decreased by -9.12% |
| Sep 30, 23 | 699.02 K Increased by +55.78% | -4.06 M Increased by +71.19% | Decreased by -581.24% Increased by +81.51% |